
Academic Journal
Q1Clinical Therapeutics
About Clinical Therapeutics
About Clinical Therapeutics
Clinical Therapeutics is a peer-reviewed scholarly journal published by Elsevier B.V. (United States). It focuses on Q1. Publication coverage spans 1977-2026.
Key indicators: ISSN 1879-114X, 0149-2918; H-index 158.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (158): Exceptionally high — 158 articles have each been cited at least 158 times. This indicates deep, sustained influence in the field.
Publishing in Clinical Therapeutics
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Clinical Therapeutics?
1879-114X, 0149-2918.
Who publishes Clinical Therapeutics?
Elsevier B.V..
What are Clinical Therapeutics's metrics?
H-index 158.
Where do I submit to Clinical Therapeutics?
Via the official website.
Is Clinical Therapeutics peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Health Systems, Economic Evaluations, Quality of Life; Diabetes Treatment and Management; Pharmaceutical Economics and Policy; Pharmaceutical studies and practices; Diverse Scientific and Economic Studies; Lipoproteins and Cardiovascular Health.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
4,240.00 USD; 3,970.00 EUR; 3,390.00 GBP; 525,890.00 JPY
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Reviews
Community Reviews
Version History
October 9, 2026 at 9:00 pm
October 2, 2026